The Gorter Model is dedicated to the treatment of cancer using immune-supportive, nontoxic therapies and also treat patients living with other chronic diseases, such as infections with hepatitis B and C and HIV. This program was developed by Robert Gorter, MD, PhD, over more than four decades of research, clinical experience and after surviving cancer himself.

The Gorter Model applies innovative, nontoxic approaches in the treatment of cancer and chronic viral infections. The goal of the treatment is to improve the immune system (“immune restoration”). Traditional academic (western) medicine is being combined with new therapies, which have a broad basis in science and developed according to the highest standards of research and peer review.

The therapies and protocols are integrated in a schedule designed specifically for each patient. There are multiple forms of nontoxic cancer therapies included in the Gorter Model:

In 2011, the Nobel Prize in Physiology and Medicine was awarded to the researchers who discovered the function of the dendritic cells and the immune system in recognizing and battling cancer cells. Ralph M. Steinman received one-half of the Nobel Prize for his discovery of the dendritic cell and its role in adaptive immunity. This award demonstrates the significance of this cell type in health and disease. Experts expect that within a few years, dendritic cells will become a part of the standard treatment of various forms of cancer.